Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AUR-109 by Orion for Pulmonary Fibrosis: Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Pulmonary Fibrosis. According to GlobalData, Phase II...
AUR-109 by Orion for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Kidney Cancer (Renal Cell Cancer). According to...
AUR-109 by Orion for Liver Cancer: Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Liver Cancer. According to GlobalData, Phase II...
AUR-109 by Orion for Ovarian Cancer: Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
AUR-109 by Orion for Lung Cancer: Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Lung Cancer. According to GlobalData, Phase II...
AUR-109 by Orion for Breast Cancer: Likelihood of Approval
AUR-109 is under clinical development by Orion and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...